The On1 restorative concept1 was unveiled at Nobel Biocare’s Global Symposium in June and since then has attracted significant interest. This was again the case at the 2016 European Association Osseointegration (EAO) Congress, held in Paris last week (September 29–October 1).
The unique On1 Base moves the restorative platform of Nobel Biocare conical connection implants from bone level to tissue level. It remains in position from implant placement to finalization, which leaves the soft tissue undisturbed for optimized healing.
One of the experts behind the On1 concept, Dr. Bernard Touati, who is based in Paris, held a one-on-one Q&A session at EAO, answering delegate’s questions on the concept. He then took to the stage during the Nobel Biocare Satellite Symposium to further explore the clinical benefits offered by this new solution.
The symposium was moderated by another Paris-based clinician, Dr. Hadi Antoun. Preceding Dr. Touati on stage was Dr. Bart Vandenberghe from Belgium, who discussed the key considerations when using CBCT scanners for diagnostic imaging.
All-on-4® experts share their knowledge
The second half of the session focused on refining approaches for managing the terminal and failing dentition with the All-on-4® treatment concept. After advice on effectively communicating the benefits of the All-on-4® approach to patients, Germany’s Dr. Hannes Wachtel handed over to renowned All-on-4® treatment concept pioneer Dr. Paulo Malo. Dr. Malo presented the options for effective, esthetic restorations with the All-on-4® treatment concept, and its evolution thanks to development such as an extended line of NobelSpeedy implants the introduction of the Multi-unit Abutment Plus.
Dr. Armando Lopes hosts All-on-4 treatment concept hands-on training at EAO 2016.
The All-on-4® treatment concept was also the theme of Nobel Biocare’s sold-out hands-on session at the congress, hosted by Dr. Malo’s colleague Dr. Armando Lopes. Dr. Lopes took attendees through the steps for converting a denture into an immediate temporary bridge for All-on-4® patients.
Clinicians looking to learn more about All-on-4® can download a new e-book about the treatment concept here.
More to explore
The On1 Concept is under FDA 510(k) review and is currently not available in the US.
creos xenogain may not be regulatory cleared/released for sale in all markets. Please contact your local Nobel Biocare sales office for current product assortment and availability